Past Director of the Pediatric Unit and School of Pediatrics in the University of L’Aquila, Italy.
Expert in prenatal and postnatal diagnosis and therapy of CMV infection.
Author of 348 publications (IF 962).
Guest Editor of "Prenatal therapy of congenital cytomegalovirus infection". Clin Infect Dis Suppl 4, vol 57, 15 Sept 2015.
Referee for 43 international Journals.
Outstanding publications on congenital CMV infection:
Nigro G, Scholz H, Bartmann U. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr 1994;124:318-22. Reviewed in Year Book of Infectious Diseases 1996: pag 167-8.
Nigro G, et al. Rapid progression of HIV disease in children with cytomegalovirus DNAemia. AIDS 1996;10:1127-33. .
Nigro G, et al. Passive maternal immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-62. Reviewed in Pediatrics 2006.
Nigro G, et al.Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy – a case-control study of the outcome in children. J Infect Dis http://jid.oxfordjournals.org/December 4, 2011 .
Nigro G, Adler SP; Congenital Cytomegalic Disease Collaborating Group. High-dose cytomegalovirus (CMV) hyperimmune globulin and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary CMV infection. Clin Infect Dis. 2020;71:1491-8.
Research Keywords & Expertise
Pregnancy
Antiviral strategies
Primary cytomegaloviru...
CMV screening
Hyperimmune globulin
Fingerprints
71%
Pregnancy
25%
Primary cytomegalovirus infection
25%
Hyperimmune globulin
5%
CMV screening
Short Biography
Past Director of the Pediatric Unit and School of Pediatrics in the University of L’Aquila, Italy.
Expert in prenatal and postnatal diagnosis and therapy of CMV infection.
Author of 348 publications (IF 962).
Guest Editor of "Prenatal therapy of congenital cytomegalovirus infection". Clin Infect Dis Suppl 4, vol 57, 15 Sept 2015.
Referee for 43 international Journals.
Outstanding publications on congenital CMV infection:
Nigro G, Scholz H, Bartmann U. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr 1994;124:318-22. Reviewed in Year Book of Infectious Diseases 1996: pag 167-8.
Nigro G, et al. Rapid progression of HIV disease in children with cytomegalovirus DNAemia. AIDS 1996;10:1127-33. .
Nigro G, et al. Passive maternal immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-62. Reviewed in Pediatrics 2006.
Nigro G, et al.Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy – a case-control study of the outcome in children. J Infect Dis http://jid.oxfordjournals.org/December 4, 2011 .
Nigro G, Adler SP; Congenital Cytomegalic Disease Collaborating Group. High-dose cytomegalovirus (CMV) hyperimmune globulin and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary CMV infection. Clin Infect Dis. 2020;71:1491-8.